WESTFORD, Mass.– Cynosure Lutronic, a global provider of energy-based medical aesthetic devices, announced that its XERF system, an advanced radiofrequency technology for skin tightening, has received clearance from the U.S. Food and Drug Administration.
The non-invasive XERF device is designed to tighten skin without needles, numbing, or downtime and is cleared for use on all skin types. Key features include the world’s first single-shot, multifrequency monopolar RF technology, which delivers energy at both 6.78 MHz and 2 MHz frequencies to heat tissue at multiple depths for immediate and lasting tightening. The system also incorporates Wave Fit pulse technology and Integrated Cryogen Delivery cooling to regulate energy and maintain skin surface comfort, along with a spider-pattern tip that enhances safety and treatment precision.
“Securing clearance for the XERF device in the U.S. marks a major milestone for Cynosure Lutronic as we accelerate our growth across North America,” said Lowinn Kibbey, president, North America at Cynosure Lutronic. “The U.S. market represents one of the largest and most dynamic aesthetics markets in the world, and we’re proud to now offer patients and providers access to a breakthrough skin-tightening solution that delivers powerful results with a more comfortable, non-invasive experience.”
Jordan V. Wang, M.D., M.B.E., M.B.A., medical director at the Laser & Skin Surgery Center of Pennsylvania, added: “The XERF system incorporates the newest technology to safely deliver energy deeper down in the skin, while offering intelligent cooling for superior protection and patient comfort.”
